Login / Signup

Decision Support Tools for Regenerative Medicine: Systematic Review.

Ching LamEdward MeinertAbrar AlturkistaniAlison R CarterJeffrey M KarpAidong YangDavid BrindleyZhanfeng Cui
Published in: Journal of medical Internet research (2018)
Our review identified a limited number of decisional tools. While the monoclonal antibodies and biologics decisional tool domain has been well developed and has shown great importance in driving more cost-effective manufacturing processes and better investment decisions, there is a lot to be learned in the regenerative medicine domain. There is ample space for expansion, especially with regard to autologous cell therapies, tissue engineering, and gene therapies. To consider the problem more comprehensively, the full needle-to-needle process should be modeled and evaluated.
Keyphrases